Replacement of the Trabecular Meshwork Cells—A Way Ahead in IOP Control?
Glaucoma is one of the leading causes of vision loss worldwide, characterised with irreversible optic nerve damage and progressive vision loss. Primary open-angle glaucoma (POAG) is a subset of glaucoma, characterised by normal anterior chamber angle and raised intraocular pressure (IOP). Reducing I...
Main Authors: | Xiaochen Fan, Emine K. Bilir, Olivia A. Kingston, Rachel A. Oldershaw, Victoria R. Kearns, Colin E. Willoughby, Carl M. Sheridan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/9/1371 |
Similar Items
-
Exploiting biomaterial approaches to manufacture an artificial trabecular meshwork: A progress report
by: Devon J. Crouch, et al.
Published: (2021-03-01) -
Apoptosis in the iris and trabecular meshwork of medically treated and untreated primary open angle glaucoma patients
by: Zeynep Aktas, et al.
Published: (2013-12-01) -
A20 Attenuates the Fibrotic Response in the Trabecular Meshwork
by: Philip Mzyk, et al.
Published: (2022-02-01) -
Overexpression and Activation of αvβ3 Integrin Differentially Affects TGFβ2 Signaling in Human Trabecular Meshwork Cells
by: Mark S. Filla, et al.
Published: (2021-07-01) -
An Optimized Method to Decellularize Human Trabecular Meshwork
by: Devon J. Crouch, et al.
Published: (2022-04-01)